nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.114	0.197	CbGbCtD
Promethazine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0841	0.146	CbGbCtD
Promethazine—ABCB1—Betamethasone—ankylosing spondylitis	0.0741	0.128	CbGbCtD
Promethazine—ABCB1—Prednisolone—ankylosing spondylitis	0.0731	0.127	CbGbCtD
Promethazine—ABCB1—Prednisone—ankylosing spondylitis	0.0691	0.12	CbGbCtD
Promethazine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0444	0.077	CbGbCtD
Promethazine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0431	0.0747	CbGbCtD
Promethazine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0406	0.0704	CbGbCtD
Promethazine—ABCB1—Methotrexate—ankylosing spondylitis	0.0347	0.06	CbGbCtD
Promethazine—Nerve injury—Prednisolone—ankylosing spondylitis	0.014	0.0459	CcSEcCtD
Promethazine—Nerve injury—Dexamethasone—ankylosing spondylitis	0.0117	0.0383	CcSEcCtD
Promethazine—Nerve injury—Betamethasone—ankylosing spondylitis	0.0117	0.0383	CcSEcCtD
Promethazine—Nerve injury—Prednisone—ankylosing spondylitis	0.0102	0.0334	CcSEcCtD
Promethazine—Abscess—Prednisolone—ankylosing spondylitis	0.00387	0.0127	CcSEcCtD
Promethazine—Appetite absent—Methotrexate—ankylosing spondylitis	0.00374	0.0122	CcSEcCtD
Promethazine—Necrosis—Methylprednisolone—ankylosing spondylitis	0.00358	0.0117	CcSEcCtD
Promethazine—Abscess—Triamcinolone—ankylosing spondylitis	0.00356	0.0117	CcSEcCtD
Promethazine—Abscess—Methylprednisolone—ankylosing spondylitis	0.00355	0.0116	CcSEcCtD
Promethazine—Necrosis—Betamethasone—ankylosing spondylitis	0.00325	0.0107	CcSEcCtD
Promethazine—Necrosis—Dexamethasone—ankylosing spondylitis	0.00325	0.0107	CcSEcCtD
Promethazine—Abscess—Dexamethasone—ankylosing spondylitis	0.00323	0.0106	CcSEcCtD
Promethazine—Abscess—Betamethasone—ankylosing spondylitis	0.00323	0.0106	CcSEcCtD
Promethazine—Extravasation—Dexamethasone—ankylosing spondylitis	0.00293	0.00959	CcSEcCtD
Promethazine—Extravasation—Betamethasone—ankylosing spondylitis	0.00293	0.00959	CcSEcCtD
Promethazine—Necrosis—Prednisone—ankylosing spondylitis	0.00283	0.00929	CcSEcCtD
Promethazine—Abscess—Prednisone—ankylosing spondylitis	0.00281	0.00921	CcSEcCtD
Promethazine—Dermatitis contact—Triamcinolone—ankylosing spondylitis	0.00278	0.00912	CcSEcCtD
Promethazine—Paralysis—Methotrexate—ankylosing spondylitis	0.00268	0.00877	CcSEcCtD
Promethazine—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00263	0.00862	CcSEcCtD
Promethazine—Delirium—Prednisone—ankylosing spondylitis	0.00259	0.00847	CcSEcCtD
Promethazine—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.00257	0.00841	CcSEcCtD
Promethazine—Dermatitis contact—Dexamethasone—ankylosing spondylitis	0.00252	0.00827	CcSEcCtD
Promethazine—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.00252	0.00827	CcSEcCtD
Promethazine—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00242	0.00793	CcSEcCtD
Promethazine—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00241	0.00791	CcSEcCtD
Promethazine—Necrosis—Methotrexate—ankylosing spondylitis	0.00237	0.00776	CcSEcCtD
Promethazine—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.00236	0.00774	CcSEcCtD
Promethazine—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.00235	0.00772	CcSEcCtD
Promethazine—Abscess—Methotrexate—ankylosing spondylitis	0.00235	0.0077	CcSEcCtD
Promethazine—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00219	0.00719	CcSEcCtD
Promethazine—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00219	0.00719	CcSEcCtD
Promethazine—Apnoea—Methotrexate—ankylosing spondylitis	0.00219	0.00719	CcSEcCtD
Promethazine—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.00214	0.00702	CcSEcCtD
Promethazine—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.00214	0.00702	CcSEcCtD
Promethazine—Extravasation—Methotrexate—ankylosing spondylitis	0.00213	0.00698	CcSEcCtD
Promethazine—Irritability—Methylprednisolone—ankylosing spondylitis	0.00195	0.00638	CcSEcCtD
Promethazine—Euphoric mood—Prednisone—ankylosing spondylitis	0.00191	0.00626	CcSEcCtD
Promethazine—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00187	0.00611	CcSEcCtD
Promethazine—Irritability—Dexamethasone—ankylosing spondylitis	0.00177	0.0058	CcSEcCtD
Promethazine—Irritability—Betamethasone—ankylosing spondylitis	0.00177	0.0058	CcSEcCtD
Promethazine—Asthma—Triamcinolone—ankylosing spondylitis	0.00177	0.00579	CcSEcCtD
Promethazine—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00175	0.00572	CcSEcCtD
Promethazine—Coma—Methotrexate—ankylosing spondylitis	0.0017	0.00557	CcSEcCtD
Promethazine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00156	0.00513	CcSEcCtD
Promethazine—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00156	0.00511	CcSEcCtD
Promethazine—Irritability—Prednisone—ankylosing spondylitis	0.00154	0.00505	CcSEcCtD
Promethazine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00154	0.00504	CcSEcCtD
Promethazine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00144	0.00472	CcSEcCtD
Promethazine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00144	0.00471	CcSEcCtD
Promethazine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.0014	0.0046	CcSEcCtD
Promethazine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00137	0.0045	CcSEcCtD
Promethazine—Erythema—Prednisolone—ankylosing spondylitis	0.00134	0.00438	CcSEcCtD
Promethazine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00131	0.00428	CcSEcCtD
Promethazine—Bradycardia—Betamethasone—ankylosing spondylitis	0.00131	0.00428	CcSEcCtD
Promethazine—Irritability—Methotrexate—ankylosing spondylitis	0.00129	0.00422	CcSEcCtD
Promethazine—Hallucination—Betamethasone—ankylosing spondylitis	0.00128	0.00418	CcSEcCtD
Promethazine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00128	0.00418	CcSEcCtD
Promethazine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00126	0.00414	CcSEcCtD
Promethazine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00126	0.00413	CcSEcCtD
Promethazine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00126	0.00413	CcSEcCtD
Promethazine—Depression—Prednisone—ankylosing spondylitis	0.00124	0.00407	CcSEcCtD
Promethazine—Erythema—Triamcinolone—ankylosing spondylitis	0.00123	0.00403	CcSEcCtD
Promethazine—Erythema—Methylprednisolone—ankylosing spondylitis	0.00123	0.00402	CcSEcCtD
Promethazine—Syncope—Prednisolone—ankylosing spondylitis	0.0012	0.00393	CcSEcCtD
Promethazine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00118	0.00385	CcSEcCtD
Promethazine—Asthma—Methotrexate—ankylosing spondylitis	0.00117	0.00382	CcSEcCtD
Promethazine—Convulsion—Prednisolone—ankylosing spondylitis	0.00116	0.0038	CcSEcCtD
Promethazine—CALM3—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00115	0.00979	CbGpPWpGaD
Promethazine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00115	0.00375	CcSEcCtD
Promethazine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00115	0.00375	CcSEcCtD
Promethazine—Bradycardia—Prednisone—ankylosing spondylitis	0.00114	0.00373	CcSEcCtD
Promethazine—Erythema—Dexamethasone—ankylosing spondylitis	0.00112	0.00366	CcSEcCtD
Promethazine—Erythema—Betamethasone—ankylosing spondylitis	0.00112	0.00366	CcSEcCtD
Promethazine—CALM1—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00111	0.00947	CbGpPWpGaD
Promethazine—CALM2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00111	0.00947	CbGpPWpGaD
Promethazine—Hallucination—Prednisone—ankylosing spondylitis	0.00111	0.00364	CcSEcCtD
Promethazine—Syncope—Triamcinolone—ankylosing spondylitis	0.0011	0.00362	CcSEcCtD
Promethazine—Syncope—Methylprednisolone—ankylosing spondylitis	0.0011	0.00361	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00109	0.00358	CcSEcCtD
Promethazine—Oedema—Prednisolone—ankylosing spondylitis	0.00109	0.00358	CcSEcCtD
Promethazine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00108	0.00354	CcSEcCtD
Promethazine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00108	0.00354	CcSEcCtD
Promethazine—Shock—Prednisolone—ankylosing spondylitis	0.00107	0.00352	CcSEcCtD
Promethazine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00107	0.00349	CcSEcCtD
Promethazine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00107	0.00349	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00106	0.00349	CcSEcCtD
Promethazine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00106	0.00349	CcSEcCtD
Promethazine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00104	0.00341	CcSEcCtD
Promethazine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00104	0.00341	CcSEcCtD
Promethazine—Depression—Methotrexate—ankylosing spondylitis	0.00104	0.0034	CcSEcCtD
Promethazine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00102	0.00336	CcSEcCtD
Promethazine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00101	0.00331	CcSEcCtD
Promethazine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.001	0.00329	CcSEcCtD
Promethazine—Oedema—Triamcinolone—ankylosing spondylitis	0.001	0.00329	CcSEcCtD
Promethazine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.001	0.00328	CcSEcCtD
Promethazine—Syncope—Dexamethasone—ankylosing spondylitis	0.001	0.00328	CcSEcCtD
Promethazine—Syncope—Betamethasone—ankylosing spondylitis	0.001	0.00328	CcSEcCtD
Promethazine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000998	0.00327	CcSEcCtD
Promethazine—Shock—Triamcinolone—ankylosing spondylitis	0.000988	0.00324	CcSEcCtD
Promethazine—Insomnia—Prednisolone—ankylosing spondylitis	0.000988	0.00324	CcSEcCtD
Promethazine—Shock—Methylprednisolone—ankylosing spondylitis	0.000986	0.00323	CcSEcCtD
Promethazine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000981	0.00322	CcSEcCtD
Promethazine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000981	0.00322	CcSEcCtD
Promethazine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00098	0.00321	CcSEcCtD
Promethazine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000978	0.0032	CcSEcCtD
Promethazine—Erythema—Prednisone—ankylosing spondylitis	0.000972	0.00319	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00097	0.00318	CcSEcCtD
Promethazine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000967	0.00317	CcSEcCtD
Promethazine—Convulsion—Betamethasone—ankylosing spondylitis	0.000967	0.00317	CcSEcCtD
Promethazine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000947	0.0031	CcSEcCtD
Promethazine—Anxiety—Betamethasone—ankylosing spondylitis	0.000947	0.0031	CcSEcCtD
Promethazine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000936	0.00307	CcSEcCtD
Promethazine—Pain—Prednisolone—ankylosing spondylitis	0.000934	0.00306	CcSEcCtD
Promethazine—Vision blurred—Prednisone—ankylosing spondylitis	0.000916	0.003	CcSEcCtD
Promethazine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000911	0.00299	CcSEcCtD
Promethazine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000911	0.00299	CcSEcCtD
Promethazine—Oedema—Betamethasone—ankylosing spondylitis	0.000911	0.00299	CcSEcCtD
Promethazine—Oedema—Dexamethasone—ankylosing spondylitis	0.000911	0.00299	CcSEcCtD
Promethazine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000908	0.00298	CcSEcCtD
Promethazine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000906	0.00297	CcSEcCtD
Promethazine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0009	0.00295	CcSEcCtD
Promethazine—Shock—Betamethasone—ankylosing spondylitis	0.000896	0.00294	CcSEcCtD
Promethazine—Shock—Dexamethasone—ankylosing spondylitis	0.000896	0.00294	CcSEcCtD
Promethazine—Agitation—Prednisone—ankylosing spondylitis	0.000893	0.00293	CcSEcCtD
Promethazine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000892	0.00292	CcSEcCtD
Promethazine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000892	0.00292	CcSEcCtD
Promethazine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000889	0.00291	CcSEcCtD
Promethazine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000889	0.00291	CcSEcCtD
Promethazine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000884	0.0029	CcSEcCtD
Promethazine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000882	0.00289	CcSEcCtD
Promethazine—Syncope—Prednisone—ankylosing spondylitis	0.000872	0.00286	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—ankylosing spondylitis	0.00087	0.00285	CcSEcCtD
Promethazine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000866	0.00284	CcSEcCtD
Promethazine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000864	0.00283	CcSEcCtD
Promethazine—Pain—Triamcinolone—ankylosing spondylitis	0.000859	0.00281	CcSEcCtD
Promethazine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000855	0.0028	CcSEcCtD
Promethazine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000851	0.00279	CcSEcCtD
Promethazine—Hypotension—Betamethasone—ankylosing spondylitis	0.000851	0.00279	CcSEcCtD
Promethazine—Convulsion—Prednisone—ankylosing spondylitis	0.000842	0.00276	CcSEcCtD
Promethazine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000828	0.00271	CcSEcCtD
Promethazine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000826	0.00271	CcSEcCtD
Promethazine—Anxiety—Prednisone—ankylosing spondylitis	0.000825	0.0027	CcSEcCtD
Promethazine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000824	0.0027	CcSEcCtD
Promethazine—Insomnia—Betamethasone—ankylosing spondylitis	0.000824	0.0027	CcSEcCtD
Promethazine—Erythema—Methotrexate—ankylosing spondylitis	0.000813	0.00266	CcSEcCtD
Promethazine—HRH4—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000811	0.00691	CbGpPWpGaD
Promethazine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000802	0.00263	CcSEcCtD
Promethazine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000802	0.00263	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000793	0.0026	CcSEcCtD
Promethazine—Oedema—Prednisone—ankylosing spondylitis	0.000793	0.0026	CcSEcCtD
Promethazine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000792	0.0026	CcSEcCtD
Promethazine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000792	0.0026	CcSEcCtD
Promethazine—Fatigue—Betamethasone—ankylosing spondylitis	0.000786	0.00257	CcSEcCtD
Promethazine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000786	0.00257	CcSEcCtD
Promethazine—Shock—Prednisone—ankylosing spondylitis	0.000781	0.00256	CcSEcCtD
Promethazine—Pain—Betamethasone—ankylosing spondylitis	0.000779	0.00255	CcSEcCtD
Promethazine—Pain—Dexamethasone—ankylosing spondylitis	0.000779	0.00255	CcSEcCtD
Promethazine—Tachycardia—Prednisone—ankylosing spondylitis	0.000774	0.00254	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000766	0.00251	CcSEcCtD
Promethazine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000751	0.00246	CcSEcCtD
Promethazine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000751	0.00246	CcSEcCtD
Promethazine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000744	0.00633	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00073	0.00622	CbGpPWpGaD
Promethazine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000727	0.00238	CcSEcCtD
Promethazine—Dizziness—Prednisolone—ankylosing spondylitis	0.000722	0.00237	CcSEcCtD
Promethazine—CALM3—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000722	0.00615	CbGpPWpGaD
Promethazine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00072	0.00236	CcSEcCtD
Promethazine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000719	0.00613	CbGpPWpGaD
Promethazine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000719	0.00613	CbGpPWpGaD
Promethazine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000719	0.00236	CcSEcCtD
Promethazine—Insomnia—Prednisone—ankylosing spondylitis	0.000718	0.00235	CcSEcCtD
Promethazine—CHRM2—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000717	0.0061	CbGpPWpGaD
Promethazine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00071	0.00233	CcSEcCtD
Promethazine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000709	0.00232	CcSEcCtD
Promethazine—Convulsion—Methotrexate—ankylosing spondylitis	0.000704	0.00231	CcSEcCtD
Promethazine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000698	0.00229	CcSEcCtD
Promethazine—CALM2—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000698	0.00595	CbGpPWpGaD
Promethazine—CALM1—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000698	0.00595	CbGpPWpGaD
Promethazine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00069	0.00226	CcSEcCtD
Promethazine—Rash—Prednisolone—ankylosing spondylitis	0.000689	0.00226	CcSEcCtD
Promethazine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000688	0.00225	CcSEcCtD
Promethazine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000686	0.00225	CcSEcCtD
Promethazine—Fatigue—Prednisone—ankylosing spondylitis	0.000684	0.00224	CcSEcCtD
Promethazine—Headache—Prednisolone—ankylosing spondylitis	0.000684	0.00224	CcSEcCtD
Promethazine—Constipation—Prednisone—ankylosing spondylitis	0.000679	0.00222	CcSEcCtD
Promethazine—Confusional state—Methotrexate—ankylosing spondylitis	0.000669	0.00219	CcSEcCtD
Promethazine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000664	0.00218	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000663	0.00217	CcSEcCtD
Promethazine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000663	0.00217	CcSEcCtD
Promethazine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000654	0.00214	CcSEcCtD
Promethazine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000654	0.00214	CcSEcCtD
Promethazine—Asthenia—Betamethasone—ankylosing spondylitis	0.000654	0.00214	CcSEcCtD
Promethazine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000649	0.00213	CcSEcCtD
Promethazine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000645	0.00211	CcSEcCtD
Promethazine—Pruritus—Betamethasone—ankylosing spondylitis	0.000645	0.00211	CcSEcCtD
Promethazine—Rash—Triamcinolone—ankylosing spondylitis	0.000633	0.00208	CcSEcCtD
Promethazine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000633	0.00207	CcSEcCtD
Promethazine—Rash—Methylprednisolone—ankylosing spondylitis	0.000632	0.00207	CcSEcCtD
Promethazine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000631	0.00207	CcSEcCtD
Promethazine—Headache—Triamcinolone—ankylosing spondylitis	0.000629	0.00206	CcSEcCtD
Promethazine—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000629	0.00535	CbGpPWpGaD
Promethazine—Headache—Methylprednisolone—ankylosing spondylitis	0.000628	0.00206	CcSEcCtD
Promethazine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000623	0.00204	CcSEcCtD
Promethazine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000623	0.00204	CcSEcCtD
Promethazine—Hypotension—Methotrexate—ankylosing spondylitis	0.00062	0.00203	CcSEcCtD
Promethazine—HRH4—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000618	0.00526	CbGpPWpGaD
Promethazine—Dizziness—Betamethasone—ankylosing spondylitis	0.000603	0.00197	CcSEcCtD
Promethazine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000603	0.00197	CcSEcCtD
Promethazine—Insomnia—Methotrexate—ankylosing spondylitis	0.0006	0.00197	CcSEcCtD
Promethazine—Somnolence—Methotrexate—ankylosing spondylitis	0.00059	0.00193	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000584	0.00191	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000576	0.00189	CcSEcCtD
Promethazine—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000575	0.0049	CbGpPWpGaD
Promethazine—Rash—Betamethasone—ankylosing spondylitis	0.000574	0.00188	CcSEcCtD
Promethazine—Rash—Dexamethasone—ankylosing spondylitis	0.000574	0.00188	CcSEcCtD
Promethazine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000574	0.00188	CcSEcCtD
Promethazine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000574	0.00188	CcSEcCtD
Promethazine—Fatigue—Methotrexate—ankylosing spondylitis	0.000572	0.00187	CcSEcCtD
Promethazine—Headache—Betamethasone—ankylosing spondylitis	0.000571	0.00187	CcSEcCtD
Promethazine—Headache—Dexamethasone—ankylosing spondylitis	0.000571	0.00187	CcSEcCtD
Promethazine—Asthenia—Prednisone—ankylosing spondylitis	0.000569	0.00187	CcSEcCtD
Promethazine—Pain—Methotrexate—ankylosing spondylitis	0.000567	0.00186	CcSEcCtD
Promethazine—Pruritus—Prednisone—ankylosing spondylitis	0.000561	0.00184	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000546	0.00179	CcSEcCtD
Promethazine—CALM3—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000546	0.00465	CbGpPWpGaD
Promethazine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000543	0.00178	CcSEcCtD
Promethazine—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000535	0.00455	CbGpPWpGaD
Promethazine—CHRM4—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000531	0.00452	CbGpPWpGaD
Promethazine—CALM1—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000528	0.0045	CbGpPWpGaD
Promethazine—CALM2—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000528	0.0045	CbGpPWpGaD
Promethazine—CALM3—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000525	0.00447	CbGpPWpGaD
Promethazine—Dizziness—Prednisone—ankylosing spondylitis	0.000525	0.00172	CcSEcCtD
Promethazine—CHRM5—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000509	0.00433	CbGpPWpGaD
Promethazine—CALM2—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000508	0.00432	CbGpPWpGaD
Promethazine—CALM1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000508	0.00432	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000504	0.00429	CbGpPWpGaD
Promethazine—Rash—Prednisone—ankylosing spondylitis	0.0005	0.00164	CcSEcCtD
Promethazine—Dermatitis—Prednisone—ankylosing spondylitis	0.0005	0.00164	CcSEcCtD
Promethazine—Headache—Prednisone—ankylosing spondylitis	0.000497	0.00163	CcSEcCtD
Promethazine—CHRM2—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000495	0.00421	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000492	0.00419	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000476	0.00405	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000476	0.00405	CbGpPWpGaD
Promethazine—Asthenia—Methotrexate—ankylosing spondylitis	0.000476	0.00156	CcSEcCtD
Promethazine—Pruritus—Methotrexate—ankylosing spondylitis	0.000469	0.00154	CcSEcCtD
Promethazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000455	0.00388	CbGpPWpGaD
Promethazine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000454	0.00149	CcSEcCtD
Promethazine—Dizziness—Methotrexate—ankylosing spondylitis	0.000439	0.00144	CcSEcCtD
Promethazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000436	0.00371	CbGpPWpGaD
Promethazine—CALM3—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000435	0.00371	CbGpPWpGaD
Promethazine—CALM3—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000435	0.0037	CbGpPWpGaD
Promethazine—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000421	0.00358	CbGpPWpGaD
Promethazine—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000421	0.00358	CbGpPWpGaD
Promethazine—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00042	0.00358	CbGpPWpGaD
Promethazine—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00042	0.00358	CbGpPWpGaD
Promethazine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000419	0.00357	CbGpPWpGaD
Promethazine—Rash—Methotrexate—ankylosing spondylitis	0.000418	0.00137	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000418	0.00137	CcSEcCtD
Promethazine—Headache—Methotrexate—ankylosing spondylitis	0.000415	0.00136	CcSEcCtD
Promethazine—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000393	0.00335	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000391	0.00333	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000391	0.00333	CbGpPWpGaD
Promethazine—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000373	0.00318	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000372	0.00317	CbGpPWpGaD
Promethazine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000366	0.00312	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000363	0.00309	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000361	0.00307	CbGpPWpGaD
Promethazine—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00036	0.00307	CbGpPWpGaD
Promethazine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000359	0.00306	CbGpPWpGaD
Promethazine—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000358	0.00305	CbGpPWpGaD
Promethazine—CHRM3—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000357	0.00304	CbGpPWpGaD
Promethazine—CHRM2—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000356	0.00303	CbGpPWpGaD
Promethazine—CHRM2—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000354	0.00301	CbGpPWpGaD
Promethazine—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000354	0.00301	CbGpPWpGaD
Promethazine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000353	0.003	CbGpPWpGaD
Promethazine—HRH4—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000349	0.00297	CbGpPWpGaD
Promethazine—CHRM4—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000347	0.00295	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000345	0.00293	CbGpPWpGaD
Promethazine—CHRM5—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000332	0.00283	CbGpPWpGaD
Promethazine—HRH4—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000317	0.0027	CbGpPWpGaD
Promethazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000314	0.00267	CbGpPWpGaD
Promethazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000309	0.00263	CbGpPWpGaD
Promethazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000308	0.00262	CbGpPWpGaD
Promethazine—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	0.000307	0.00262	CbGpPWpGaD
Promethazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000307	0.00261	CbGpPWpGaD
Promethazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000306	0.0026	CbGpPWpGaD
Promethazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000303	0.00258	CbGpPWpGaD
Promethazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000302	0.00257	CbGpPWpGaD
Promethazine—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.000299	0.00254	CbGpPWpGaD
Promethazine—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.000297	0.00253	CbGpPWpGaD
Promethazine—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.000297	0.00253	CbGpPWpGaD
Promethazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000297	0.00253	CbGpPWpGaD
Promethazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000296	0.00252	CbGpPWpGaD
Promethazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000295	0.00251	CbGpPWpGaD
Promethazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000294	0.0025	CbGpPWpGaD
Promethazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000291	0.00247	CbGpPWpGaD
Promethazine—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.000289	0.00246	CbGpPWpGaD
Promethazine—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.000289	0.00246	CbGpPWpGaD
Promethazine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000283	0.00241	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000283	0.00241	CbGpPWpGaD
Promethazine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000274	0.00233	CbGpPWpGaD
Promethazine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000274	0.00233	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000273	0.00233	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000273	0.00233	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.000269	0.00229	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.00026	0.00222	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.00026	0.00222	CbGpPWpGaD
Promethazine—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000257	0.00219	CbGpPWpGaD
Promethazine—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000254	0.00216	CbGpPWpGaD
Promethazine—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000254	0.00216	CbGpPWpGaD
Promethazine—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000249	0.00212	CbGpPWpGaD
Promethazine—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000249	0.00212	CbGpPWpGaD
Promethazine—DRD2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000239	0.00203	CbGpPWpGaD
Promethazine—HTR2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000235	0.002	CbGpPWpGaD
Promethazine—HRH1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000234	0.002	CbGpPWpGaD
Promethazine—CHRM1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000234	0.00199	CbGpPWpGaD
Promethazine—CHRM3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000233	0.00198	CbGpPWpGaD
Promethazine—CHRM2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000231	0.00196	CbGpPWpGaD
Promethazine—ADRA1A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00023	0.00196	CbGpPWpGaD
Promethazine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000227	0.00193	CbGpPWpGaD
Promethazine—HRH4—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000226	0.00192	CbGpPWpGaD
Promethazine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000219	0.00187	CbGpPWpGaD
Promethazine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000219	0.00187	CbGpPWpGaD
Promethazine—CALM3—Disease—ANTXR2—ankylosing spondylitis	0.000209	0.00178	CbGpPWpGaD
Promethazine—CALM2—Disease—ANTXR2—ankylosing spondylitis	0.000202	0.00172	CbGpPWpGaD
Promethazine—CALM1—Disease—ANTXR2—ankylosing spondylitis	0.000202	0.00172	CbGpPWpGaD
Promethazine—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	0.000196	0.00167	CbGpPWpGaD
Promethazine—CHRM4—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000196	0.00167	CbGpPWpGaD
Promethazine—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	0.00019	0.00162	CbGpPWpGaD
Promethazine—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	0.00019	0.00162	CbGpPWpGaD
Promethazine—CHRM5—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000188	0.0016	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000187	0.00159	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1R2—ankylosing spondylitis	0.000181	0.00154	CbGpPWpGaD
Promethazine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000181	0.00154	CbGpPWpGaD
Promethazine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000181	0.00154	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000178	0.00151	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1R2—ankylosing spondylitis	0.000175	0.00149	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1R2—ankylosing spondylitis	0.000175	0.00149	CbGpPWpGaD
Promethazine—CALM3—Immune System—ERAP1—ankylosing spondylitis	0.000171	0.00146	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00017	0.00145	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	0.000169	0.00144	CbGpPWpGaD
Promethazine—CALM2—Immune System—ERAP1—ankylosing spondylitis	0.000166	0.00141	CbGpPWpGaD
Promethazine—CALM1—Immune System—ERAP1—ankylosing spondylitis	0.000166	0.00141	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	0.000164	0.00139	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000164	0.00139	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000162	0.00138	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000157	0.00134	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000157	0.00134	CbGpPWpGaD
Promethazine—CALM3—Immune System—CARD9—ankylosing spondylitis	0.000157	0.00134	CbGpPWpGaD
Promethazine—CALM2—Immune System—CARD9—ankylosing spondylitis	0.000152	0.00129	CbGpPWpGaD
Promethazine—CALM1—Immune System—CARD9—ankylosing spondylitis	0.000152	0.00129	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	0.000149	0.00127	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000137	0.00117	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000135	0.00115	CbGpPWpGaD
Promethazine—CHRM2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000135	0.00115	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—MMP3—ankylosing spondylitis	0.000133	0.00114	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000133	0.00113	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000132	0.00113	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000132	0.00112	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000132	0.00112	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00013	0.00111	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00013	0.00111	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000127	0.00108	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000124	0.00105	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—B3GNT2—ankylosing spondylitis	0.000123	0.00105	CbGpPWpGaD
Promethazine—CALM3—Disease—B3GNT2—ankylosing spondylitis	0.000123	0.00105	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000123	0.00104	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000121	0.00103	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000121	0.00103	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00012	0.00102	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00012	0.00102	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00012	0.00102	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00012	0.00102	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00012	0.00102	CbGpPWpGaD
Promethazine—CALM1—Disease—B3GNT2—ankylosing spondylitis	0.000119	0.00101	CbGpPWpGaD
Promethazine—CALM2—Disease—B3GNT2—ankylosing spondylitis	0.000119	0.00101	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000118	0.00101	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000118	0.00101	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	0.000106	0.000902	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000105	0.000895	CbGpPWpGaD
Promethazine—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	0.000103	0.000878	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000101	0.000859	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000101	0.000857	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.0001	0.000852	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	0.0001	0.000851	CbGpPWpGaD
Promethazine—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	9.97e-05	0.000849	CbGpPWpGaD
Promethazine—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	9.97e-05	0.000849	CbGpPWpGaD
Promethazine—CALM3—Immune System—HLA-C—ankylosing spondylitis	9.85e-05	0.000839	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	9.76e-05	0.000831	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	9.76e-05	0.000831	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	9.68e-05	0.000824	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	9.68e-05	0.000824	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	9.67e-05	0.000824	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	9.67e-05	0.000824	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	9.6e-05	0.000818	CbGpPWpGaD
Promethazine—CALM2—Immune System—HLA-C—ankylosing spondylitis	9.53e-05	0.000811	CbGpPWpGaD
Promethazine—CALM1—Immune System—HLA-C—ankylosing spondylitis	9.53e-05	0.000811	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	9.29e-05	0.000791	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	9.29e-05	0.000791	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	8.9e-05	0.000757	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—CRP—ankylosing spondylitis	8.84e-05	0.000753	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—MMP3—ankylosing spondylitis	8.73e-05	0.000743	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	8.61e-05	0.000733	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	8.61e-05	0.000733	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—MMP3—ankylosing spondylitis	8.59e-05	0.000731	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—MMP3—ankylosing spondylitis	8.57e-05	0.000729	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1RN—ankylosing spondylitis	8.55e-05	0.000728	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—CRP—ankylosing spondylitis	8.55e-05	0.000728	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—CRP—ankylosing spondylitis	8.55e-05	0.000728	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—MMP3—ankylosing spondylitis	8.54e-05	0.000727	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—MMP3—ankylosing spondylitis	8.51e-05	0.000725	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	8.47e-05	0.000721	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—MMP3—ankylosing spondylitis	8.43e-05	0.000718	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—MMP3—ankylosing spondylitis	8.41e-05	0.000716	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1RN—ankylosing spondylitis	8.28e-05	0.000705	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1RN—ankylosing spondylitis	8.28e-05	0.000705	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	8.2e-05	0.000698	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	8.2e-05	0.000698	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	7.81e-05	0.000665	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD79A—ankylosing spondylitis	7.51e-05	0.000639	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MMP3—ankylosing spondylitis	7.48e-05	0.000637	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	7.36e-05	0.000627	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	7.34e-05	0.000625	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	7.3e-05	0.000622	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD79A—ankylosing spondylitis	7.27e-05	0.000619	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD79A—ankylosing spondylitis	7.27e-05	0.000619	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PTGER4—ankylosing spondylitis	7.24e-05	0.000616	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MMP3—ankylosing spondylitis	7.16e-05	0.00061	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	7.13e-05	0.000607	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PTGER4—ankylosing spondylitis	7.12e-05	0.000607	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PTGER4—ankylosing spondylitis	7.11e-05	0.000605	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PTGER4—ankylosing spondylitis	7.08e-05	0.000603	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PTGER4—ankylosing spondylitis	7.06e-05	0.000601	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PTGER4—ankylosing spondylitis	6.99e-05	0.000596	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PTGER4—ankylosing spondylitis	6.97e-05	0.000594	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	6.89e-05	0.000587	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	6.89e-05	0.000587	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1A—ankylosing spondylitis	6.16e-05	0.000524	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD40LG—ankylosing spondylitis	6.12e-05	0.000521	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1A—ankylosing spondylitis	5.96e-05	0.000507	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1A—ankylosing spondylitis	5.96e-05	0.000507	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD40LG—ankylosing spondylitis	5.92e-05	0.000504	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD40LG—ankylosing spondylitis	5.92e-05	0.000504	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	5.91e-05	0.000503	CbGpPWpGaD
Promethazine—CALM3—Immune System—HLA-B—ankylosing spondylitis	5.82e-05	0.000496	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	5.72e-05	0.000487	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	5.72e-05	0.000487	CbGpPWpGaD
Promethazine—CALM1—Immune System—HLA-B—ankylosing spondylitis	5.63e-05	0.00048	CbGpPWpGaD
Promethazine—CALM2—Immune System—HLA-B—ankylosing spondylitis	5.63e-05	0.00048	CbGpPWpGaD
Promethazine—CALM3—Immune System—HLA-A—ankylosing spondylitis	5.4e-05	0.000459	CbGpPWpGaD
Promethazine—CALM2—Immune System—HLA-A—ankylosing spondylitis	5.22e-05	0.000444	CbGpPWpGaD
Promethazine—CALM1—Immune System—HLA-A—ankylosing spondylitis	5.22e-05	0.000444	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP3—ankylosing spondylitis	5.15e-05	0.000439	CbGpPWpGaD
Promethazine—CALM3—Immune System—CRP—ankylosing spondylitis	5.15e-05	0.000438	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP3—ankylosing spondylitis	5.07e-05	0.000432	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP3—ankylosing spondylitis	5.06e-05	0.000431	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP3—ankylosing spondylitis	5.04e-05	0.00043	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP3—ankylosing spondylitis	5.03e-05	0.000428	CbGpPWpGaD
Promethazine—CALM3—Disease—HLA-A—ankylosing spondylitis	4.98e-05	0.000424	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP3—ankylosing spondylitis	4.98e-05	0.000424	CbGpPWpGaD
Promethazine—CALM2—Immune System—CRP—ankylosing spondylitis	4.98e-05	0.000424	CbGpPWpGaD
Promethazine—CALM1—Immune System—CRP—ankylosing spondylitis	4.98e-05	0.000424	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP3—ankylosing spondylitis	4.97e-05	0.000423	CbGpPWpGaD
Promethazine—CALM3—Immune System—TLR4—ankylosing spondylitis	4.93e-05	0.00042	CbGpPWpGaD
Promethazine—CALM2—Disease—HLA-A—ankylosing spondylitis	4.82e-05	0.00041	CbGpPWpGaD
Promethazine—CALM1—Disease—HLA-A—ankylosing spondylitis	4.82e-05	0.00041	CbGpPWpGaD
Promethazine—CALM1—Immune System—TLR4—ankylosing spondylitis	4.77e-05	0.000406	CbGpPWpGaD
Promethazine—CALM2—Immune System—TLR4—ankylosing spondylitis	4.77e-05	0.000406	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	4.21e-05	0.000358	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	4.07e-05	0.000347	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	4.07e-05	0.000347	CbGpPWpGaD
